December 4, 2018
A drug originally developed for prostate cancer may have exciting potential for treating Parkinson’s. The study, funded by Parkinson’s UK, suggests that the drug, tasquinimod, which is not yet on the market, works by controlling genes that may cause Parkinson’s. This happens when the drug interacts with a protein inside […]